Media center

We provide ongoing updates on our commercial, clinical and financial progress through regular press releases, presentations and webcasts, which can be accessed through the company’s media center.

Press Releases

Circassia Announces Board Changes

Click here to download the full press release Oxford, UK – 5 December 2019: Circassia Pharmaceuticals plc (“Circassia” or “the Company”; LSE: CIR), a specialty biopharmaceutical company focused on respiratory disease, today announces a number...

Circassia Announces Duaklir® US Launch at American College of Chest Physicians’ CHEST Annual Meeting 2019

Click here to download the full press release – Duaklir® launch expands Circassia’s US portfolio of COPD products alongside Tudorza® – Oxford, UK and Morrisville, NC, United States – 21 October 2019: Circassia Pharmaceuticals plc...

Interim results for the six months ended 30 June 2019

Click here to download the full 2019 interim results Oxford, UK – 26 September 2019: Circassia Pharmaceuticals plc (“Circassia” or “the Company”) (LSE: CIR), a specialty pharmaceutical company focused on respiratory disease, today announces its...

More press releases

In this section

Press releases

Presentations

Webcasts & audio

Image library

Media contacts